Literature DB >> 21224056

Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid.

Valerie P J Saw1, Enno Schmidt, Ifeoma Offiah, Grazyna Galatowicz, Detlef Zillikens, John K G Dart, Virginia L Calder, Julie T Daniels.   

Abstract

Ocular mucous membrane pemphigoid is an immunobullous disease in which excessive conjunctival fibrosis causes blindness, and the pathogenesis of scarring is incompletely understood. To establish whether profibrotic fibroblasts with an altered phenotype exist in ocular mucous membrane pemphigoid, we compared the functional characteristics of pemphigoid conjunctival fibroblasts to normal conjunctival fibroblasts with respect to cell division; migration; collagen contraction; matrix metalloproteinase, secretion of collagen and chemokines; and myofibroblast differentiation. We found that pemphigoid fibroblasts showed increased cell division (P = 0.01), increased migration in serum-free medium (72 ± 18 migrated cells versus 33 ± 11, P = 0.04), increased collagen contraction in the presence of 10 ng/ml tumor necrosis factor-α, increased collagen type I secretion (P = 0.03), increased secretion of matrix metalloproteinase-3 (P = 0.03), and increased secretion of eotaxin in response to interleukin-13 (P = 0.04). Differences between pemphigoid and normal conjunctival fibroblasts with respect to collagen contraction and MMP secretion in the presence of interleukin-13 were also observed. Together, these findings indicate that pemphigoid conjunctival fibroblasts have a profibrotic phenotype that is maintained in vitro. No differences between pemphigoid fibroblasts obtained from acutely inflamed versus clinically uninflamed conjunctiva were observed. Developing effective antifibrotic therapies will require understanding of the mechanisms that both induce and maintain the profibrotic phenotype. Copyright Â
© 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21224056      PMCID: PMC3069913          DOI: 10.1016/j.ajpath.2010.11.013

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  What did we learn by studying scleroderma fibroblasts?

Authors:  M Trojanowska
Journal:  Clin Exp Rheumatol       Date:  2004 Jan-Feb       Impact factor: 4.473

2.  The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon's fibroblasts.

Authors:  P T Khaw; S Ward; A Porter; I Grierson; R A Hitchings; N S Rice
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-05       Impact factor: 4.799

3.  Benign mucous membrane pemphigoid.

Authors:  K M Hardy; H O Perry; G C Pingree; T J Kirby
Journal:  Arch Dermatol       Date:  1971-11

4.  Ocular cicatricial pemphigoid.

Authors:  B J Mondino; S I Brown
Journal:  Ophthalmology       Date:  1981-02       Impact factor: 12.079

5.  A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.

Authors:  D Zillikens; Y Kawahara; A Ishiko; H Shimizu; J Mayer; C V Rank; Z Liu; G J Giudice; H H Tran; M P Marinkovich; E B Brocker; T Hashimoto
Journal:  J Invest Dermatol       Date:  1996-06       Impact factor: 8.551

6.  Hyperproliferation of conjunctival fibroblasts from patients with cicatricial pemphigoid.

Authors:  M I Roat; G Sossi; C Y Lo; R A Thoft
Journal:  Arch Ophthalmol       Date:  1989-07

7.  The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment.

Authors:  B J Mondino; S I Brown; S Lempert; M S Jenkins
Journal:  Ophthalmology       Date:  1979-04       Impact factor: 12.079

8.  Cytokines in the conjunctiva of acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis.

Authors:  W Bernauer; P Wright; J K Dart; J N Leonard; S Lightman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-10       Impact factor: 3.117

9.  In vitro studies of the contractility of cell types involved in proliferative vitreoretinopathy.

Authors:  A Mazure; I Grierson
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-11       Impact factor: 4.799

10.  Role of macrophage migration inhibitory factor in conjunctival pathology in ocular cicatricial pemphigoid.

Authors:  Mohammed S Razzaque; C Stephen Foster; A Razzaque Ahmed
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-04       Impact factor: 4.799

View more
  16 in total

1.  Upper and lower conjunctival fornix depth in healthy white caucasian eyes: a method of objective assessment.

Authors:  G Jutley; D Carpenter; S Hau; D Booth; H A Jasim; E Tay; C Daniel; V Saw
Journal:  Eye (Lond)       Date:  2016-07-08       Impact factor: 3.775

Review 2.  Ocular mucous membrane pemphigoid: a review.

Authors:  Samanta Taurone; Marialuisa Spoletini; Massimo Ralli; Pietro Gobbi; Marco Artico; Laszlò Imre; Cecília Czakò; Illés Kovàcs; Antonio Greco; Alessandra Micera
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 3.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

4.  Limbal Fibroblasts Maintain Normal Phenotype in 3D RAFT Tissue Equivalents Suggesting Potential for Safe Clinical Use in Treatment of Ocular Surface Failure.

Authors:  Isobel Massie; Sarah B Dale; Julie T Daniels
Journal:  Tissue Eng Part C Methods       Date:  2014-12-17       Impact factor: 3.056

5.  Classical dendritic cells mediate fibrosis directly via the retinoic acid pathway in severe eye allergy.

Authors:  Sarah D Ahadome; Rose Mathew; Nancy J Reyes; Priyatham S Mettu; Scott W Cousins; Virginia L Calder; Daniel R Saban
Journal:  JCI Insight       Date:  2016-08-04

6.  Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring.

Authors:  Sarah D Ahadome; David J Abraham; Suryanarayana Rayapureddi; Valerie P Saw; Daniel R Saban; Virginia L Calder; Jill T Norman; Markella Ponticos; Julie T Daniels; John K Dart
Journal:  JCI Insight       Date:  2016-08-04

Review 7.  Linking immune responses with fibrosis in allergic eye disease.

Authors:  Sarah B Dale; Daniel R Saban
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-10

8.  Bone mesenchymal stem cells differentiate into myofibroblasts in the tumor microenvironment.

Authors:  Jing Zhang; Dingqi Sun; Qiang Fu; Qingwei Cao; Hui Zhang; Keqin Zhang
Journal:  Oncol Lett       Date:  2016-05-30       Impact factor: 2.967

Review 9.  Molecular mechanisms and treatments for ocular symblephara.

Authors:  Aditi Swarup; Christopher N Ta; Albert Y Wu
Journal:  Surv Ophthalmol       Date:  2021-04-29       Impact factor: 6.048

10.  Fibroblasts profiling in scarring trachoma identifies IL-6 as a functional component of a fibroblast-macrophage pro-fibrotic and pro-inflammatory feedback loop.

Authors:  Jenny Z Kechagia; Daniel G Ezra; Matthew J Burton; Maryse Bailly
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.